Skip to main content
SpringerLink
Log in

Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Loss of heterozygosity (LOH) in loci of the 10q23 region that harbor the PTEN gene and mutations in the sequence of this gene have been found in several primary human tumors including breast carcinomas, suggesting that this gene could be implicated in their pathogenesis. We investigated allelic losses in microsatellites of the 10q23 region, and their correlations with nine pathologic parameters in 105 breast carcinomas. The LOH analysis was performcd by amplifying DNA by PCR, using five markers of the 10q23 region (D10S1687, D10S541, D10S2491, D10S583 and D10S571). LOH in at least one marker of the PTEN region was found in 29.5% of tumors. The statistical comparison between carcinomas with and without LOH in terms of the pathologic parameters showed significant differences in age (p=0.03), lymph node metastases (p=0.02), and higher histological grade (p=0.02); a trend toward significance was found for progesterone receptors (p=0.05). LOH in an individual marker and statistically significant relationships to tumor characteristics were observed at locus D10S541 for lymph node metastases (p=0.04), at D10S2491 (intragenic to the PTEN gene) for lymph node metastases (p=0.02), and at D10S583 for progesterone receptors (p=0.01) and for high grade (p=0.03). These results suggest the PTEN gene, or other genes of the 10q23 region, could be functionally related to breast cancer, probably influencing the development of histological features associated with poor prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH: Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 10: 2243–2246, 1995

    Google Scholar 

  2. Gray IC, Phillips SMA, Lee SJ. Neoptolemos JP, Weissenbach J, Spurr NK: Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55: 4800–4803, 1995

    Google Scholar 

  3. Li J, Yen C, Liaw D, Podsypanlna K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, lttman M, Tycko B, Hibshoosh H, Wigler MH, Parsons R: PTEN, a putative protein tyrosin phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943–1947, 1997

    Google Scholar 

  4. Steck PA, Perhouse MA, Jasser SA, Yunk WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF, Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 15: 356–362, 1997

    Google Scholar 

  5. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D: Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57: 4997–5000, 1997

    Google Scholar 

  6. Pesche S, Latil A, Muzeau F, Cussenot O, Fournier G, Longy M, Eng C, Lidereau R: PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Oncogene 16: 2879–2883, 1998

    Google Scholar 

  7. Rasheed BKA, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4187–4190, 1997

    Google Scholar 

  8. Wang SI, Puc J, Li J, Bruce NJ, Cairns P, Sidransky D, Parsons R: Somatic mutations of PTEN in glioblastomas multiforme. Cancer Res 57: 4183–4186, 1997

    Google Scholar 

  9. Dahia PLM, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, Wallin G, Parsons R, Longy M, Larsson C, Eng C: Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 57: 4710–4713, 1997

    Google Scholar 

  10. Risinger JI, Hayes AK, Berchuck A, Barret JC: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 57: 4736–4738, 1997

    Google Scholar 

  11. Tashiro H, Blazes MS., Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH: Mutations in PTEN are frequent in endometrial carcinomas but rare in other common gynecological malignancies. Cancer Res 57: 3935–3940, 1997

    Google Scholar 

  12. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuci M, Sato S, Yin J, Wang S. Abraham JM, Souza RF, Smolionski KN, Meltzer SJ, Horil A: PTEN is frequently mutated in primary endometrial carcinomas. Nature Genet 17: 143–144, 1997

    Google Scholar 

  13. Rhei E, Kang L, Bogomonniy F, Federichi MG, Borgen PI, Boyd J: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57: 3657–3659, 1997

    Google Scholar 

  14. Guldberg P, Straten PT, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660–3663, 1997

    Google Scholar 

  15. Cairns P, Evron E, Okami K, Halachmi N, Esteller M, Herman JG, Bose S, Wang SI, Parsons R, Sidransky D: Point mutations and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene 16: 3215–3218, 1998

    Google Scholar 

  16. Liaw D, Marsh DJ. Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R: Germline mutations of the PTEN gene in Cowden disease, and inherited breast and thyroid cancer syndrome. Nature Genet 16: 64–67, 1997

    Google Scholar 

  17. Marsh DJ, Dahia PLM, Zheng Z, L iaw D, Parsons R, Gorlin RJ, Eng C: Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nature Genet 16: 333–334, 1997

    Google Scholar 

  18. Teng DHF, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Nagger A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WKA, Fujil G, Berson A, Bookstein R, Bolen JB, Tavtigian SV, Steck PA: MMAC1/PTEN mutations in primary tumor specimens and tumor cells lines. Cancer Res 57: 5221–5225, 1997

    Google Scholar 

  19. Singh B, Ittmann MM, Krolewski JJ: sporadic breast cancer exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus. Genes Chromosomes Cancer 21: 166–171, 1998

    Google Scholar 

  20. Bose S, Wang SI, Terry MB, Hibshoosh H, Arsons R: Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas. Oncogene 17: 123–127, 1998

    Google Scholar 

  21. Tsou HC, Teng DH, Ping XL, Brancoloini V, Davis T, Hu R, Xie XX, Gruener AC, Schrager CA, Christiano AM, Eng C, Steck P, Ott J, Tavtigian SV, Peacocke M: The role of MMAC1 mutations in early-onset breast cancer: causative in association with Cowden syndrome and excluded in BRCA1-negative cases. Am J Hum Genet 61: 1036–1043, 1997

    Google Scholar 

  22. Lynch ED, Ostermeyer EA, Lee MK Arena JF, Ji H, Dann J, Swisshelm K, Suchard D, Macleod PM, Kvinnsland S, Gjertsen BT, Heimdal K, Lubs H, Moller P, King MC: Inherited mutations in PTEN that are associated with breast cancer. Cowden disease, and juvenile polyposis. Am J Hum Genet 61: 1254–1260, 1997

    Google Scholar 

  23. Tsou HC, Ping XL, Xie XX, Gruener AC, Zhang H, Nini R, Swisshelm K, Sybert V, Diamond TM, Sutphen R, Peacocke M: The genetic basis of Cowden's syndrome: three novel mutations in PTEN/MMAC1/TEP1. Hum Genet 102: 467–473, 1998

    Google Scholar 

  24. Kellsell DP, Spurr NK, Barnes DM, Gusterson B, Bishop DT: Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet 347: 1554–1555, 1996

    Google Scholar 

  25. Bcckmann MW, Picard F, An HX, van Roeyen CRC, Dominik SI, Mosny DS, Schnurch HG, Bender HG, Niederacher D: Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 73: 1220–1226, 1996

    Google Scholar 

  26. Paulson TG, Wright FA, Parker BA, Russack V, Wahl GM: Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res 56: 4021–4026, 1996

    Google Scholar 

  27. Oto M, Miyake S, Yuasa Y: Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. Ann Biochem 213: 19–22, 1993

    Google Scholar 

  28. Tamura M, Gu J, Matsumoto K, Aota S-I, Parsons R, Yamada KM: Inhibition of cell migration, spreading and focal adhesions by tumor suppressor PTEN. Science 280: 1614–1617, 1998

    Google Scholar 

  29. Furnari FB, Huang H-JS, Cavenee WK: The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58: 5002–5008, 1998

    Google Scholar 

  30. Li J, Simpson L, Takahashi M, Miliaresis Ch, Myers MP, Tonks N, Parsons R: The PTEN/MMAC1 tumor suppressor induces cell deaths that is rescued by the AKT/protein kinase B oncogene. Cancer Res 58: 5667–5672, 1998

    Google Scholar 

  31. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP: Pten is essential for embryonic development and tumour suppression. Nature Genet 19: 348–355, 1998

    Google Scholar 

  32. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB, Bova GS: Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58: 204–209, 1998

    Google Scholar 

  33. Bièche I, Liderean R: Genetic alteration in breast cancer. Genes Chromosomes Cancer 14: 227–251, 1995

    Google Scholar 

  34. Devillee P, Cornelisse C: Somatic genetic changes in human breast cancer. Biochim Biophys Acta 198: 113–130, 1994

    Google Scholar 

  35. Kerangueven F, Noguchi T, Coulier F, Allione F, Wargniez V, Simony-Lafontaine J, Longy M, Jackemier J, Sobol H, Eisinger F, Birnbaum D: Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res 57: 5469–5474, 1997

    Google Scholar 

  36. Phelan CM, Borg A, Cuny M, Crichton DN, Baldersson T, Andersen TI, Caligo MA, Lidereau R, Lidblom A, Seitz S, Kelsell D, Hamann U, Rio P, Thorlacious S, Papp J, Olah E, Ponder B, B ignon YJ, Scherneck S, Barkardottir R, Borresen-Dale AL, Eyfjörd J, Theillet C, Thompson AM. Deville P, Larsson C: Consortium study on 1280 breast carcinomas: allelic loss on chromosome target subregions associated with family history and clinical parameters. Cancer Res 58: 1004–1012, 1998

    Google Scholar 

  37. Harris JR, Morrow M, Norton L: Malignant tumors of the breast. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer Principles and Practice of Oncology, 5th edition, Vol 2. pp 1557–1616 Lippincott-Noreu, Philadelphia, 1997

    Google Scholar 

  38. van der Berg J, Johannsson O, Hakansson S, Olsson H, Borg A: Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer 74: 1615–1619, 1996

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medical Oncology, and Pathology, Clinica Puerta de Hierro, Madrid, Spain

    Jose M. Garcia, Jose M. Silva, Gemma Dominguez, Rocio Gonzalez, Mariano Provencio, Pilar España & Felix Bonilla

  2. Pathology, Clinica Puerta de Hierro, Madrid, Spain

    Antonia Navarro

  3. Department of Pathology, Hospital Gregorio Marañon, Madrid, Spain

    Luis Carretero

Authors
  1. Jose M. Garcia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jose M. Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gemma Dominguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rocio Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antonia Navarro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luis Carretero
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mariano Provencio
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pilar España
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Felix Bonilla
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garcia, J.M., Silva, J.M., Dominguez, G. et al. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype. Breast Cancer Res Treat 57, 237–243 (1999). https://doi.org/10.1023/A:1006273516976

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006273516976

Search

Navigation